Dendritic cells as targets for therapy in rheumatoid arthritis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Dendritic cells (DCs) are central in inducing immunity and in mediating immune tolerance in their role as professional antigen-presenting cells. In the absence of DCs, a fatal autoimmunity develops in animal models. Although the role of DCs has been investigated extensively in the pathogenesis of rheumatoid arthritis (RA), it remains unclear whether DCs initiate autoimmunity in this disease. Nevertheless, evidence points towards a significant role for DCs in disease maintenance and progression. Current biologic therapies target cytokine products of antigen-presenting cells, such as tumor necrosis factor, interleukin-1 and interleukin-6. Emerging therapies for RA exploit the tolerogenic capacity of DCs. 'Tolerogenic' DCs can be generated from myeloid precursors ex vivo, loaded with antigen, and manipulated to suppress autoimmune responses in vivo, through the induction of activation-induced cell death, anergy, and/or regulatory T cells. Cells that are primed by DCs, such as B cells, type 1 and type 17 T helper cells, and that have been implicated in certain models of autoimmunity, are also being considered as additional targets for immune-based therapy. Studies to validate these approaches to ameliorate autoimmunity will be necessary before their application in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956 · cited 1×
“Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a negative regulator of T-cell activation that is also expressed on T REG cells”
BackgroundDivergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669
Plasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551 · cited 1×
“DCs also secrete cytokines, directing naive T cells toward different types of T helper (T H ) cell: T H 1, T H 2 or T H 17 cells”
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 1×
“IL-17 stimulates fibroblasts, endothelial and epithelial cells to produce IL-6 and IL-8, recruits neutrophils and monocytes”
BackgroundGenovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
Humby, F., Bombardieri, M., Manzo, A., Kelly, S., Blades, M. C., Kirkham, B., Spencer, J., & Pitzalis, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.0060001 · Cited by 537 · cited 1×
“These centers contain plasma cells that express activation-induced cytidine deaminase and produce anti-citrullinated protein antibodies (ACPAs)”
BackgroundLoss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice
Travis, M. A., Reizis, B., Melton, A. C., Masteller, E., Tang, Q., Proctor, J. M., Wang, Y., Bernstein, X., Huang, X., Reichardt, L. F., et al. (2007) · Nature · doi:10.1038/nature06110 · Cited by 503
Kirkham, B. W., Lassere, M. N., Edmonds, J. P., Juhasz, K. M., Bird, P. A., Lee, C. S., Shnier, R., & Portek, I. J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21749 · Cited by 336
Type 17 T helper cells-origins, features and possible roles in rheumatic disease.
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.80 · Cited by 212 · cited 1×
“However, the identification of T H 17 cells and IL-17 and IL-23 within affected tissues and/or fluids of patients has implicated both T H 1 and T H 17 cells in RA pathogenesis”
Background
Cited by
Yap, H.-Y., Tee, S. Z.-Y., Wong, M. M.-T., Chow, S.-K., Peh, S.-C., & Teow, S.-Y. (2018) · Cells · doi:10.3390/cells7100161 · Cited by 486
Treatment of rheumatoid arthritis: state of the art 2009
van Vollenhoven, R. F. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.182 · Cited by 277
Gao, B., Kong, Q., Kemp, K., Zhao, Y.-S., & Fang, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118462109 · Cited by 98
Potential efficacy of dendritic cell immunomodulation in the treatment of osteoarthritis
Alahdal, M., Zhang, H., Huang, R., Sun, W., Deng, Z., Duan, L., Ouyang, H., & Wang, D. (2021) · Rheumatology · doi:10.1093/rheumatology/keaa745 · Cited by 50
Amoah, B. P., Yang, H., Zhang, P., Su, Z., & Xu, H. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12298 · Cited by 41
Metadata
- Authors
- Khan, S., Greenberg, J. D., & Bhardwaj, N.
- Venue
- Nature Reviews Rheumatology
- Published
- 2009-10
- Volume
- 5
- Issue
- 10
- Pages
- 566-571
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2056032873
- Cited by
- 127
- References
- 9
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dendritic cells as targets for therapy in rheumatoid arthritis. https://app.cochat.ai/papers/10.1038/nrrheum.2009.185
- The paper
- Khan, S., Greenberg, J. D., & Bhardwaj, N. (2009). Dendritic cells as targets for therapy in rheumatoid arthritis. Nature Reviews Rheumatology. https://doi.org/10.1038/nrrheum.2009.185
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.